{
    "nctId": "NCT04657328",
    "briefTitle": "Prospective Multicenter Study on Clinical Application of Sonazoid in Breast Tumor",
    "officialTitle": "Contrast-enhanced Ultrasound in Breast Tumor by Sonazoid",
    "overallStatus": "UNKNOWN",
    "conditions": "Ultrasound",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 181,
    "primaryOutcomeMeasure": "Diagnostic performance of contrast-enhanced ultrasound in breast tumor by Sonazoid.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Conventional ultrasonography suggested definite lesions in the breast;\n2. In addition to conventional ultrasound, there is also enhanced MRI examination;\n3. There are no contraindications for puncture biopsy, and pathological examination (cytology, histology) is planned to examine the patients with target lesions\n4. Patients volunteered to participate in the study and signed informed consent.-\n\nExclusion Criteria:\n\n1. Those who are known to be allergic to ultrasound contrast agents;\n2. The subject has a history of allergy to eggs or egg products (i.e. skin rash, dyspnea, swelling of the mouth or throat, hypotension or shock, etc.)\n3. Arteriovenous (left and right) shunt patients in the heart and lungs\n4. Patients with serious heart disease or serious lung disease\n5. Patients who are pregnant, possibly pregnant or lactating\n6. Patients who cannot receive contrast agent MRI\n7. In addition, the investigator or the patient that the investigator considers not suitable to participate in this study",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}